Condition
Diabetic Foot Ulcer Ischemic
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Enrolling By Invitation1
Terminated1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05762432Not ApplicableRecruiting
Diabetic Foot Ulcer Research Study
NCT07023965Enrolling By Invitation
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
NCT04078854Not ApplicableTerminated
The Impact of Sexual Health and Amputation Focused Education on Regulation of Glucose and Amputation Prevention
Showing all 3 trials